Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...
Detroit Pistons star point guard Cade Cunningham has been diagnosed with a collapsed lung and will be re-evaluated in two ...
Objectives To evaluate how recurrent COVID-19 infections influence the clinical course of patients with chronic obstructive pulmonary disease (COPD), focusing on moderate-to-severe symptom flare-ups, ...
Background: Chronic obstructive pulmonary disease (COPD) and stroke remain major contributors to U.S. mortality. Although age-adjusted mortality rates (AAMRs) have declined, disparities across sex, ...
GSK’s respiratory drug lineup spans a newly approved product for chronic obstructive pulmonary disease as well as therapeutic candidates in various stages of clinical development for treating this ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “Clinicians can take away from our article that COPD is ...
Merck & Co. said Wednesday it will acquire London-based Verona Pharma in a $10 billion all-cash deal, bolstering its respiratory treatment portfolio as the company moves to reduce long-term dependence ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. Home Smart: Penthouse perch in Seaport SJC allows AG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results